Total trials
122
Active
28
Phase 3
1
Total enrollment
18,341
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine | — | — | — | — | — | 1 |
Next readouts
- 2026-12-31
Top conditions
- Chronic Obstructive Pulmonary Disease8
- Obesity7
- Healthy5
- Protein Metabolism5
- Periodontitis4
- Cardiovascular Diseases4
- Cancer3
- Snoring3
Frequently asked questions about Texas A&M University
- How many clinical trials does Texas A&M University have on ClinicalTrials.gov?
- Texas A&M University is listed as the lead sponsor on 122 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Texas A&M University's trials are in Phase 3?
- 1 of Texas A&M University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Texas A&M University focus on?
- Texas A&M University's most-studied conditions on ClinicalTrials.gov are Chronic Obstructive Pulmonary Disease, Obesity, Healthy, Protein Metabolism, Periodontitis.
- When are Texas A&M University's next clinical trial readouts?
- Texas A&M University has 1 upcoming primary-completion readout tracked here; the soonest is “Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression”, expected around 2026-12-31.